Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer

The aim of the study was to examine the effect of a new tripeptide, Leu-Ile-Lys, on an experimental indometacin-induced gastric ulcer in rats. Materials and Methods: The experiment was performed with 24 male Wistar rats (average weight of 150 g). Rats were randomly divided into 3 groups: Group 1(n...

Full description

Bibliographic Details
Main Authors: Aleksandr Yu. Zharikov, Samira E. Lorents, Igor P. Bobrov, Olesya N. Mazko, Olesya G. Makarova
Format: Article
Language:English
Published: International Medical Research and Development Corporation 2018-12-01
Series:International Journal of Biomedicine
Subjects:
Online Access:http://ijbm.org/articles/IJBM_8(4)_OA_17.pdf
_version_ 1819200203943575552
author Aleksandr Yu. Zharikov
Samira E. Lorents
Igor P. Bobrov
Olesya N. Mazko
Olesya G. Makarova
author_facet Aleksandr Yu. Zharikov
Samira E. Lorents
Igor P. Bobrov
Olesya N. Mazko
Olesya G. Makarova
author_sort Aleksandr Yu. Zharikov
collection DOAJ
description The aim of the study was to examine the effect of a new tripeptide, Leu-Ile-Lys, on an experimental indometacin-induced gastric ulcer in rats. Materials and Methods: The experiment was performed with 24 male Wistar rats (average weight of 150 g). Rats were randomly divided into 3 groups: Group 1(n=8) – the ulcer control group (IIGU), Group 2 (n=8) – the experimental group (IIGU+pre-treating with the tripeptide Leu-Ile-Lys), and Group 3 (n=8) – the comparison group (IIGU+pre-treating with omeprazole). The model of IIGU in rats was performed by a single intragastric administration of indomethacin (60mg/kg in 1ml of physiological saline). In Group 1, indomethacin caused the appearance of severe injuries of the mucosa with the presence of extensive edema and leukocyte infiltration in the submucosal layer. In animals of Group 2, which were pre-treated with the tripeptide Leu-Ile-Lys, macroscopically gastric mucosa also looked smooth and atrophic changes were not found. Destructive changes were not severe; they appeared only in the form of small spot erosions. The number of spot erosions was 2.6 times less than in Group 1. The average erosion depth was 6.8 times less than in Group 1, and 2.0 times less than in Group 3. Conclusion: Results of this study demonstrated the high, comparable to the action of omeprazole, gastroprotective activity of the new tripeptide Leu-Ile-Lys.
first_indexed 2024-12-23T03:28:30Z
format Article
id doaj.art-18318d2be90b4cb78f7f6fdfe8aeb393
institution Directory Open Access Journal
issn 2158-0510
2158-0529
language English
last_indexed 2024-12-23T03:28:30Z
publishDate 2018-12-01
publisher International Medical Research and Development Corporation
record_format Article
series International Journal of Biomedicine
spelling doaj.art-18318d2be90b4cb78f7f6fdfe8aeb3932022-12-21T18:01:46ZengInternational Medical Research and Development CorporationInternational Journal of Biomedicine2158-05102158-05292018-12-018435135410.21103/Article8(4)_OA17Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric UlcerAleksandr Yu. Zharikov0Samira E. Lorents1Igor P. Bobrov2Olesya N. Mazko3Olesya G. Makarova4Altai State Medical University; Barnaul, the Russian FederationAltai State Medical University; Barnaul, the Russian FederationAltai State Medical University; Barnaul, the Russian FederationAltai State Medical University; Barnaul, the Russian FederationAltai State Medical University; Barnaul, the Russian FederationThe aim of the study was to examine the effect of a new tripeptide, Leu-Ile-Lys, on an experimental indometacin-induced gastric ulcer in rats. Materials and Methods: The experiment was performed with 24 male Wistar rats (average weight of 150 g). Rats were randomly divided into 3 groups: Group 1(n=8) – the ulcer control group (IIGU), Group 2 (n=8) – the experimental group (IIGU+pre-treating with the tripeptide Leu-Ile-Lys), and Group 3 (n=8) – the comparison group (IIGU+pre-treating with omeprazole). The model of IIGU in rats was performed by a single intragastric administration of indomethacin (60mg/kg in 1ml of physiological saline). In Group 1, indomethacin caused the appearance of severe injuries of the mucosa with the presence of extensive edema and leukocyte infiltration in the submucosal layer. In animals of Group 2, which were pre-treated with the tripeptide Leu-Ile-Lys, macroscopically gastric mucosa also looked smooth and atrophic changes were not found. Destructive changes were not severe; they appeared only in the form of small spot erosions. The number of spot erosions was 2.6 times less than in Group 1. The average erosion depth was 6.8 times less than in Group 1, and 2.0 times less than in Group 3. Conclusion: Results of this study demonstrated the high, comparable to the action of omeprazole, gastroprotective activity of the new tripeptide Leu-Ile-Lys.http://ijbm.org/articles/IJBM_8(4)_OA_17.pdfpeptic ulcerIndometacineoligopeptidesgastroprotective activity
spellingShingle Aleksandr Yu. Zharikov
Samira E. Lorents
Igor P. Bobrov
Olesya N. Mazko
Olesya G. Makarova
Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer
International Journal of Biomedicine
peptic ulcer
Indometacine
oligopeptides
gastroprotective activity
title Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer
title_full Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer
title_fullStr Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer
title_full_unstemmed Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer
title_short Pharmacologically Active Tripeptide Leu-Ile-Lys in Indomethacin-Induced Gastric Ulcer
title_sort pharmacologically active tripeptide leu ile lys in indomethacin induced gastric ulcer
topic peptic ulcer
Indometacine
oligopeptides
gastroprotective activity
url http://ijbm.org/articles/IJBM_8(4)_OA_17.pdf
work_keys_str_mv AT aleksandryuzharikov pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer
AT samiraelorents pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer
AT igorpbobrov pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer
AT olesyanmazko pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer
AT olesyagmakarova pharmacologicallyactivetripeptideleuilelysinindomethacininducedgastriculcer